Collaboration to focus on enhancing physician engagement in clinical trials and cancer research.
Massive Bio and ONCOassist have announced in a joint press release that they have entered into a strategic partnership with the aim of optimizing patient-centric care and enhancing physician engagement in clinical trials and cancer research. As a result of the joint venture, the organizations are hoping to reshape the oncology landscape.
"In the rapidly evolving realm of oncology, our partnership with ONCOassist stands as a testament to our dedication to pushing the boundaries and ensuring every cancer patient receives optimal care,” said Arturo Loaiza-Bonilla, MD, co-founder, chief medical officer, Massive Bio, in the aforementioned press release.
Reference: Massive Bio and ONCOassist® Announce Strategic Partnership at ESMO 2023. BusinessWire. October 19, 2023. Accessed October 25, 2023. https://www.businesswire.com/news/home/20231019250308/en/Massive-Bio-and-ONCOassist%C2%AE-Announce-Strategic-Partnership-at-ESMO-2023
